Consultancy position

• Leading a multinational business development, sales and marketing team across UK, Ireland and Scandinavia, including second line management of after-sales team• Accountability of the overall business within the region through department head ‘dotted line reports’ (quote-to-cash, finance, helpdesk, service, project instillations)• Coaching and management of the sales team. Ensuring robust plans are developed and executed, with regular performance analysis and guidance• Strategic business planning aligned to individual macro-economic country market environments and creating entry strategies for new markets• Market development for new technologies. Developing the messaging to target the right audience to ensure early adopters, and overseeing product launches from pilot to full commercial release• Restructuring the teams and providing career development opportunities• Ensuring lean process management across an international matrix structure

• Head of commercial activities covering the EMEA region, including P&L accountability (£28m).• Overseeing the reversal of a five-year decline in both revenue and profit, whilst developing a robust new business pipeline for continued growth.• Leading transition from low margin commodity products into higher value medical device manufacturing.• Restructuring the commercial organisation, including redundancies, redeployment and performance management.• Annual formulation of strategic action plan, forecast and budget. Presenting to international parent group board on a quarterly basis.• Providing clear guidance, management and career development for direct reports in business development, account management and customer service teams across two sites.• Overseeing new product development projects including capital investment expenditure applications.

• Strategic management of the business’s larger key accounts.• 82% increase in revenue and 8% increase in average gross margin over 4 years, driven by major new business wins, improved pricing strategies and cost-out initiatives.• Negotiation of complex long-term contracts to ensure stability and continuity of business with multi-million-dollar international accounts.• Development of strong partnerships through consultation with matrix of senior executives and key stakeholders from both parties to foster continued growth, create new business opportunities and enable successful conflict resolution.• Leading multi-national, cross-functional teams in new product development projects, from conception and prototyping, through to market launch and accelerated market share growth.• Identification and acquisition of potential new customer accounts and business opportunities.• Winner of multiple accolades, averaging 191% of base salary through accelerated bonuses for over achievement.Strategic Account Director of the Year 2013Circle of Excellence Award 2013President’s Award 2011Strategic Account Director of the Year 2011Circle of Excellence Award 2011Rookie of the Year 2011

• Responsibility for market share growth of In Vitro Diagnostic test strips.• Cross-functional collaboration with marketing and commercial teams, external medical professionals and healthcare commissioning groups to manage launch of new blood glucose monitor into primary & secondary care market.• Selection, development and coaching of new Territory Managers.2nd Place EMEA Sales Person of the Year 2009

•Management of two territories selling a portfolio of laparoscopic and surgical stapling instruments, along with vessel sealing and tissue dissection capital equipment.•Consulting in theatre with targeted surgeons, and developing strong relationships with key stakeholders (hospital management, procurement teams, Trust directors, etc).

•Arrangement of commercial and domestic finance, mortgages and bridging loans.•BtoB and BtoC sales to High Net Worth clients and business directors.

•Managed seven branches across the South of UK (7 direct reports - 32 total reports).•Managed increased lending, and decreased bad-debt write-off.

•Managed branch of 6 staff.•Regularly over-achieved lending and insurance sales targets, and managed underwriting and delinquency.